πŸ‡ΊπŸ‡Έ FDA
Patent

US 6610510

Morphogenic proteins

expired A61KA61K38/00A61P

Quick answer

US patent 6610510 (Morphogenic proteins) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P19/00, A61P43/00